| Title | Date |
|---|
| Latest results about emerging MS therapies, risk factors, disease mechanisms, rehabilitation, CCSVI, and much more presented at AAN Meeting | May 16, 2012 |
| Small Study Reports Benefit of Marijuana on MS Spasticity | May 14, 2012 |
| Speeding Clinical Trials for People with Progressive MS: Outcomes Published from an International Workshop on MS Disability Measurement Tools | May 11, 2012 |
| FDA Issues Safety Communication About Procedures to Treat CCSVI in People with MS | May 10, 2012 |
| What Triggers MS in Kids? Pediatric Network and Other Sites Recruiting for Study of Environmental and Genetic Risk Factors | Apr 25, 2012 |
| MS Trial Alert: Trial of Vitamin D Supplementation Recruiting People with Relapsing-Remitting MS | Apr 19, 2012 |
| Update: Canadian Government Chooses Research Team to Conduct Clinical Trial to Treat CCSVI | Apr 18, 2012 |
| Study shows hotter days may worsen the ability to perform mental tasks in some people with MS | Apr 12, 2012 |
| MS Trial Alert: Investigators Recruiting for Study of Daclizumab HYP Delivered in Prefilled Syringe | Apr 02, 2012 |
| National MS Society-funded study suggests balance/ eye movement training improves fatigue, balance and other symptoms in people with MS | Mar 22, 2012 |
| Study finds that virus naturally found in human genes to be active on immune cells in some people with active MS | Mar 21, 2012 |
| Study Suggests Need for Further Research on Understanding the MS Experience of Hispanics/Latinos | Mar 15, 2012 |
| Study: Woman’s Risk of Having a First Neurologic Event, Which Often Leads to MS, Decreased with Increased Number of Pregnancies | Mar 07, 2012 |
| Fast Forward and Concert Pharmaceuticals Announce Collaboration to Advance Novel Treatment for Spasticity and Pain in MS | Mar 05, 2012 |
| Biogen Idec Applies to FDA for Approval of BG-12 to Treat MS | Feb 29, 2012 |
| Results Reported in Phase II Clinical Trial of Oral Firategrast for Relapsing MS | Feb 27, 2012 |
| Cleveland Clinic’s Dr. Richard Ransohoff Wins 2012 John Dystel Prize for MS Research -- Provided far-reaching insights on immune activity in the central nervous system | Feb 21, 2012 |
| Small Trial of Patients’ Own Adult Stem Cells Appears Safe and Hints of Benefit | Feb 15, 2012 |
| Rehabilitation Technique Improves Memory and Increases Brain Activity in People with MS | Feb 14, 2012 |
| Pivotal Meeting Probes MS Therapy Use in Children | Feb 13, 2012 |
| MS Trial Alert: Investigators Recruiting for Study Comparing Exercise Programs to Improve Depression | Feb 08, 2012 |
| MS Trial Alert: Pain Study Recruiting People with MS Nationwide | Feb 07, 2012 |
| Research Teams Report on 18 Months of Progress from MS Societies’ Initial Studies on CCSVI and MS | Jan 27, 2012 |
| FDA Updates Tysabri Label to Include Lab Test that Helps Identify Person’s Risk of Developing PML | Jan 23, 2012 |
| European Medicines Agency Commences Safety Review of Gilenya | Jan 20, 2012 |
| National MS Society Convenes Summit to Explore Vitamin D Trials to Prevent MS | Jan 17, 2012 |
| MS Trial Alert: Investigators Recruiting for Studies Comparing Ocrelizumab to Rebif® in People with Relapsing MS | Jan 17, 2012 |
| Study Offers Insight on How Epstein-Barr Virus May Play a Role in MS | Jan 09, 2012 |
| Study Shows Potential of Lab Test to Detect Virus Which Causes PML in People with MS – ongoing study may help identify risk for PML in people treated with natalizumab | Dec 22, 2011 |
| Results from Trial Comparing Teriflunomide and Rebif in Relapsing MS Do Not Meet Primary Goal | Dec 20, 2011 |
| MS Trial Alert: Investigators Recruiting for Study of Ocrelizumab in Primary-Progressive MS | Dec 19, 2011 |
| Fast Forward and Lineagen to Collaborate to Develop Gene and Biomarker-Based Clinical Assays for Multiple Sclerosis | Dec 16, 2011 |
| Researchers confirm link between MS and a gene linked to vitamin D | Dec 09, 2011 |
| Great Strides Moved MS Research Forward in 2011 | Dec 07, 2011 |
| Novel Study of Underlying Disease Processes in Early MS by MS Lesion Project Team, Co-funded by Society’s Promise:2010 Initiative | Dec 07, 2011 |
| Update: Canadian Government Seeks Proposals for Clinical Trial to Treat CCSVI – Society’s funded CCSVI researchers are among those advising the agency on protocol strategies | Dec 01, 2011 |
| Tovaxin® (T cell vaccination) granted fast-track designation by FDA | Nov 29, 2011 |
| Researchers Recruiting African Americans with MS and Family Members Across the U.S. for Genetics Studies – Key to finding cause of MS and better treatments | Nov 28, 2011 |
| Positive Results Announced from Second Phase III Study of Alemtuzumab in MS | Nov 15, 2011 |
| Multiple Sclerosis Emerging Therapies Collaborative - UPDATE | Nov 14, 2011 |
| National MS Society Launches $16 Million in New Research to Stop MS, Restore Function and End MS Forever -- 32 new grants part of the $45.2 million 2012 investment in cutting-edge research | Nov 11, 2011 |
| Global MS Research Efforts Shared at ECTRIMS/ACTRIMS Meeting | Nov 10, 2011 |
| Phase II results published of clinical trial of ocrelizumab in relapsing MS | Oct 31, 2011 |
| Positive results announced from a second Phase III Trial of oral BG-12 in relapsing MS | Oct 26, 2011 |
| Fast Forward and Athersys Enter Collaboration to Support Development of MultiStem to Treat Multiple Sclerosis | Oct 24, 2011 |
| Researchers Recruiting 5,000 First-Degree Relatives of People with MS for Genetic/Environmental Research Study | Oct 17, 2011 |
| Results of successful phase III trial of oral teriflunomide for relapsing MS – reduced relapses, MRI disease activity, and higher dose reduced disability progression | Oct 05, 2011 |
| MS Trial Alert: Investigators Recruiting for Study Comparing Telephone-Delivered Self-Management Programs to Improve MS Symptoms | Sep 21, 2011 |
| Dr. Kenneth P. Johnson, One of the World’s Leading Innovators in MS Research and Treatment Has Died | Sep 08, 2011 |
| FDA Approves Botox® for Treating Urinary Incontinence in MS and other Neurologic Conditions | Aug 30, 2011 |
| Update: Ohio Stem Cell Study Recruiting People with MS -- Study supported by the CDMRP, thanks in large part to MS activists who helped secure funding | Aug 23, 2011 |
| MS Trial Alert: Investigators Recruiting for Study of Tysabri in Secondary-Progressive MS | Aug 23, 2011 |
| Global Consortium Doubles the Number of MS Risk Genes Identified | Aug 10, 2011 |
| Positive Results Announced from Phase 2 Trial of Daclizumab | Aug 10, 2011 |
| Study of Laquinimod Does Not Meet Primary Endpoint: Initial Results Announced in Press Release | Aug 02, 2011 |
| Progress in Managing MS Symptoms and Other Results Reported at CMSC Annual Meeting | Jul 27, 2011 |
| New Study on Cost Effectiveness of MS Therapies | Jul 20, 2011 |
| Research Teams Report First Year’s Progress From MS Societies’ Initial Studies on CCSVI and MS | Jul 14, 2011 |
| Positive Results Announced from First Phase III Study of Alemtuzumab in MS | Jul 12, 2011 |
| Study: Bone Health is a Concern in Early MS | Jul 12, 2011 |
| Researchers Funded by Promise:2010 Find Possible Regulator of Myelin Repair | Jun 30, 2011 |
| Fast Forward and EMD Serono Provide funding of Over $1 Million to Accelerate Early Stage Research in MS | Jun 30, 2011 |
| Company Decides Not to Seek Approval of Cladribine for MS | Jun 22, 2011 |
| MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MS | Jun 16, 2011 |
| Neurologists Begin to Build Consensus on Managing Pediatric MS and Similar Disorders | Jun 16, 2011 |
| Study of Large Population in Taiwan Finds Increased Risk of Developing MS following an Attack of Herpes Zoster | Jun 16, 2011 |
| Details About 130 Clinical Trials in MS Now Available | Jun 07, 2011 |
| Researchers Pinpoint Novel Gene-Environment Interaction in Cells from People with MS | Jun 02, 2011 |
| Study: No Link Found Between Stress and Development of Multiple Sclerosis | May 31, 2011 |
